Skip to main content

Laurion Capital Management LP

Position in JNJ — Johnson & Johnson

CIK 1390202 NEW YORK, NY

Position in JNJ

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$359,875
-$353,467 QoQ
Shares Held
1,417
-69.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#3,998
of 4,664 holders
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Dec 31, 2023
CallValue
$9,905,968
CallShares
63,200
PutValue
$9,905,968
PutShares
63,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Laurion Capital Management LP holds $13,138,022 across 6 Drug Manufacturers - General names. JNJ ranks #5 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 JNJ
Johnson & Johnson
This page
1,417 $359,875

All Filings in JNJ

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $359,875 1,417
2025-06-30 $713,342 4,670
2024-06-30 $340,552 2,330
2023-12-31 $9,905,968 63,200
2023-12-31 $9,905,968 63,200
2023-06-30 $453,524 2,740
2022-06-30 $23,323,926 131,395
2022-03-31 $35,446,000 200,000
2021-06-30 $1,048,075 6,362
2021-03-31 $3,635,750 22,122
2020-12-31 $5,653,719 35,924
2020-09-30 $4,014,698 26,966
2020-06-30 $10,350,368 73,600
2020-06-30 $15,638,056 111,200
2020-06-30 $13,758,395 97,834